Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS Trial

Bo Jan Noordman(Erasmus MC Cancer Institute), J. Jan B. van Lanschot(Erasmus MC Cancer Institute), Ernst Jan Spillenaar Bilgen(Radboud University Nijmegen), Geke A.P. Hospers(University Medical Center Groningen), Mark I. van Berge Henegouwen(University of Namur), Jannet C. Beukema(University Medical Center Groningen), Geert-Jan Creemers, Tom Rozema(Radboud University Nijmegen), R.J.B. Blaisse(Rijnstate Hospital), Bas P. L. Wijnhoven(Erasmus MC Cancer Institute), Hanneke W.M. van Laarhoven(Dutch Cancer Society), Grard A. P. Nieuwenhuijzen(Radboud University Nijmegen), Olivier R. Busch(Amsterdam Neuroscience), Cornelis J.A. Punt(Utrecht University), Herman van Dekken(Erasmus MC), Johannes J. Bonenkamp, Katharina Biermann(Rotterdam University of Applied Sciences), Miguel A. Cuesta(Hospital General Universitario de Albacete), Sjoerd M. Lagarde(University of Amsterdam), Pieter van Hagen(Erasmus MC), Janny G. Reinders(Dutch Art Institute), Maarten C.C.M. Hulshof(Academic Medical Center), Mirjam A. G. Sprangers(GGD Amsterdam), Henk M.W. Verheul(Erasmus MC Cancer Institute), Ewout W. Steyerberg(Erasmus MC), Anna H.M. Piet(Amsterdam University Medical Centers), Ate van der Gaast(Erasmus MC), Hugo W. Tilanus(Amsterdam UMC Location University of Amsterdam), John Plukker(Education Training And Research), Caroline M. van Rij(Erasmus MC), Mathilde G. E. Verdam(Leiden University), Fiebo J.W. ten Kate, Maurice J.C. van der Sangen(Radboud University Nijmegen)
Journal of Clinical Oncology
November 21, 2017
Cited by 130


Related Papers